Harrow, Inc. enters the second half of 2026 with a sharp internal contradiction — short sellers are rebuilding positions into a stock that just rallied 21% in a month, while options traders are the least bearish they've been all year.
The short side of the ledger is genuinely crowded. Short interest has climbed to 19.2% of the free float, up roughly 4% over the past month and 3.8% on the week, with FINRA's fortnightly settlement count sitting even higher at 7.3 million shares. Days-to-cover runs nearly ten, meaning any forced unwind would take the better part of two weeks. The borrow market reflects demand: availability has tightened to 34.3%, down sharply from 44.4% just a week ago and well into the "tight" range — only about one share remains available for every three already borrowed. Cost to borrow is subdued at 0.77%, down from a brief mid-month spike above 1%, suggesting that while the pool is shrinking, the scramble for borrows hasn't yet turned frantic. The 52-week availability low is 20%, and the current trajectory points in that direction.
Options positioning tells the opposite story. The put/call ratio has drifted to its lowest level of the past year at 0.164, a full standard deviation below its 20-day average of 0.174. This is emphatically not a market hedging against downside — options traders are running one of the most call-heavy setups HROW has seen in twelve months, sitting close to the 52-week low PCR of 0.156. That divergence between a rebuilding short base and call-dominated options flow is the week's central tension.
The Street remains uniformly bullish on direction but noticeably less so on price. All recent analyst actions carry Buy or Overweight ratings, yet targets have drifted lower since the Q1 miss. Cantor Fitzgerald trimmed to $88 in mid-May, while B. Riley cut to $65 in April — still well above the current $42.47 close. The consensus mean of $67.75 implies roughly 60% upside from here, a spread that reflects genuine disagreement about execution rather than conviction on direction. The bull case rests on a path to $100M revenue through salesforce expansion, a new J-Code, and fresh product launches. Bears point to the Branded segment missing Q1 estimates with guidance left unchanged, plus the structural headwind from annual deductible resets that hit the first quarter every year. Factor scores add texture: HROW ranks in the 93rd percentile for EPS surprise, a strong track record, but the short score of 79.7 places it among the most short-pressured names in the universe, and the utilization rank sits in the 9th percentile — meaning almost every other stock has more borrow availability.
The insider picture complicates the bear case. In mid-May, after the stock dropped hard on earnings, both the CEO and co-founder Mark Baum and President/CFO Andrew Boll bought shares in the open market — Baum adding 10,000 shares at $30.20 and Boll picking up 3,500 at $29.90. Two independent directors bought on the same day. That cluster of post-earnings buying from four insiders at prices roughly 30% below today's level is meaningful. The 90-day net insider position is positive, with two earlier large sells by Opaleye Management (a 10% owner) largely offsetting the picture from a share count perspective, but the directional signal from operating management buying the dip is clear.
The earnings history adds one more variable. The two most recent prints both produced day-one drops exceeding 20%, with five-day losses in the same range. Q1 2026 triggered a 24% one-day decline followed by a further drift lower. The next earnings event is scheduled for August 7. Between now and then, the question for HROW is whether the month's sharp recovery from post-earnings lows can hold against a short base that is quietly rebuilding — and whether the borrow pool tightens further as that position grows.
See the live data behind this article on ORTEX.
Open HROW on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
